comparemela.com
Home
Live Updates
Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress : comparemela.com
Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress
Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress aXess graft demonstrated excellent patency
Related Keywords
Portugal ,
United States ,
Porto ,
Italy ,
Netherlands ,
Amber Fennell Chris Welsh ,
Eliane Schutte ,
Matteo Tozzi ,
Alexander Goemans ,
Davita Venture Group ,
Consilium Strategic Communications ,
Vascular Access Society Congress ,
Life Sciences ,
Pharma Group ,
University Of Insubria ,
Vascular Access Society In Porto ,
Vascular Access Society ,
Vascular Surgery ,
Xess Vascular Graft ,
Kidney Disease ,
Kurma Partners ,
Ysios Capital ,
Grand Pharma Group ,
Exeltis ,
Presents ,
Excellent ,
Month ,
First ,
Human ,
Data ,
Rom ,
Foxess ,
Hemodialysis ,
Ascular ,
Craft ,
Trial ,
Access ,
Society ,
Congress ,
comparemela.com © 2020. All Rights Reserved.